These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10146527)

  • 1. Update in nuclear cardiology.
    Grambow DW; Schwaiger M
    Curr Opin Cardiol; 1993 Nov; 8(6):1014-20. PubMed ID: 10146527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are technetium-99m-labeled myocardial perfusion agents adequate for detection of myocardial viability?
    Caner B; Beller GA
    Clin Cardiol; 1998 Apr; 21(4):235-42. PubMed ID: 9562932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac applications of positron-emission tomography.
    Beanlands R; Schwaiger M
    Curr Opin Radiol; 1991 Dec; 3(6):817-27. PubMed ID: 1751292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of myocardial perfusion and metabolism for assessment of myocardial viability.
    Beller GA
    Q J Nucl Med; 1996 Mar; 40(1):55-67. PubMed ID: 8681014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Indications for clinical applications of positron emission tomography in cardiology. Position report of the PET Cardiology Study Group of the German Society of Nuclear Medicine and the Nuclear Cardiology Study Circle of the German Society of Cardiology].
    Z Kardiol; 1996 Jul; 85(7):453-68. PubMed ID: 8928543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging techniques in nuclear cardiology for the assessment of myocardial viability.
    Slart RH; Bax JJ; van Veldhuisen DJ; van der Wall EE; Dierckx RA; Jager PL
    Int J Cardiovasc Imaging; 2006 Feb; 22(1):63-80. PubMed ID: 16372139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of thallium-201 resting redistribution with technetium-99m-sestamibi uptake and functional response to dobutamine for assessment of myocardial viability.
    Sansoy V; Glover DK; Watson DD; Ruiz M; Smith WH; Simanis JP; Beller GA
    Circulation; 1995 Aug; 92(4):994-1004. PubMed ID: 7641384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Technetium-99m-labelled HL91 and technetium-99m-labelled MIBI SPECT imaging for the detection of ischaemic viable myocardium: a preliminary study.
    Liu M; Ma Z; Guo X; Zhu J; Su J
    Clin Physiol Funct Imaging; 2012 Jan; 32(1):25-32. PubMed ID: 22152075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of pharmacological 99mTc-sestamibi myocardial perfusion imaging with poststenotic coronary flow reserve in patients with angiographically intermediate coronary artery stenoses.
    Miller DD; Donohue TJ; Younis LT; Bach RG; Aguirre FV; Wittry MD; Goodgold HM; Chaitman BR; Kern MJ
    Circulation; 1994 May; 89(5):2150-60. PubMed ID: 8181140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial perfusion imaging using technetium-99m radiopharmaceuticals.
    Kiat H; Berman DS; Maddahi J
    Radiol Clin North Am; 1993 Jul; 31(4):795-815. PubMed ID: 8337368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial scintigraphy.
    Alexander C; Oberhausen E
    Semin Nucl Med; 1995 Apr; 25(2):195-201. PubMed ID: 7597421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Present assessment of myocardial viability by nuclear imaging.
    Saha GB; MacIntyre WJ; Brunken RC; Go RT; Raja S; Wong CO; Chen EQ
    Semin Nucl Med; 1996 Oct; 26(4):315-35. PubMed ID: 8916320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender-related imaging issues in assessment of coronary artery disease by nuclear techniques.
    Grover-McKay M
    Am J Card Imaging; 1996 Jan; 10(1):54-64. PubMed ID: 8680134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of myocardial perfusion by positron emission tomography.
    Schwaiger M; Muzik O
    Am J Cardiol; 1991 May; 67(14):35D-43D. PubMed ID: 2035433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The noninvasive assessment of myocardial viability.
    Ragosta M; Beller GA
    Clin Cardiol; 1993 Jul; 16(7):531-8. PubMed ID: 8348761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of 99mTc-sestamibi SPECT myocardial perfusion imaging with absolute coronary flow reserve by a new noninvasive Doppler method in patients with stenoses of the left anterior descending coronary artery. A preliminary report.
    Caiati C; Cioglia G; Montaldo C; Zedda N; Rubini G; Pirisi R; Iliceto S
    Cardiologia; 1999 Sep; 44(9):809-16. PubMed ID: 10609390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in nuclear cardiology in the study of coronary artery disease.
    Tamaki N; Tadamura E; Kudoh T; Hattori N; Inubushi M; Konishi J
    Ann Nucl Med; 1997 May; 11(2):55-66. PubMed ID: 9212883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Progress in nuclear cardiology: new imaging beyond perfusion and function].
    Tamaki N
    Nihon Igaku Hoshasen Gakkai Zasshi; 1999 Oct; 59(12):656-62. PubMed ID: 10565167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of myocardial viability in chronic coronary artery disease using technetium-99m sestamibi SPECT. Correlation with histologic and positron emission tomographic studies and functional follow-up.
    Maes AF; Borgers M; Flameng W; Nuyts JL; van de Werf F; Ausma JJ; Sergeant P; Mortelmans LA
    J Am Coll Cardiol; 1997 Jan; 29(1):62-8. PubMed ID: 8996296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of thallium scintigraphy and positron emission tomography.
    Niemeyer MG; Kuijper AF; Meeder JG; Cramer MJ; Cleophas AJ; van der Wall EE
    Angiology; 1997 Oct; 48(10):843-53. PubMed ID: 9342963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.